MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-24-0018532
Integrity Formulations Private Limited
Integrity Formulations Private Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.8 Cr
▼ 34% YoY
Net loss · FY 2025
₹2.36 Cr
Net margin -18.4%
EBITDA · FY 2025
-₹2.3 Cr
EBITDA margin -17.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
24
Provident fund records
Directors on board
3
As per MCA filings
About Integrity Formulations Private Limited
Data last updated:
Integrity Formulations Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24200GJ2021PTC120384. Its GSTIN is 24AAGCI0254F1Z0 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Upasna Dipesh Thakkar and Pareshkumar Narottambhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.37 Chhani Jakat Naka, Vadodara, Gujarat, India – 390024.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.8 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹2.36 Cr (net margin -18.4%) and EBITDA of -₹2.3 Cr (EBITDA margin -17.9%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years.
The company has about 24 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
Integrity Formulations Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0018532).
Company details
CIN U24200GJ2021PTC120384
Registration Number 120384
Incorporation Date 19 February 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-GJ-24-0018532
Key People
Pareshkumar Narottambhai Patel Additional Director Alkaben Sureshbhai Thakkar Additional Director Upasna Dipesh Thakkar Director Recognitions & Rankings of Integrity Formulations
Contact details
Integrity Formulations Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No.37 Chhani Jakat Naka, Vadodara, Gujarat, India – 390024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Integrity Formulations Private Limited, buy the company report.
Comprehensive company report
Integrity Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Integrity Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Integrity Formulations Private Limited, buy the company report.
Financials of Integrity Formulations Private Limited
FY 2025 filings availableIntegrity Formulations Private Limited reported revenue of ₹12.8 Cr (down 34% YoY) for FY 2025.
Revenue · FY 2025
₹12.8 Cr ▼ 34%
Net loss · FY 2025
₹2.36 Cr margin -18.4%
EBITDA · FY 2025
-₹2.3 Cr margin -17.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▲ 51%
EBITDA CAGR growth
1 year
▼ 925%
3 years · compounded
▼ 267%
Revenue fell 34% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 51%. EBITDA fell 925% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.3 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.9% | ||||
| Net Profit Margin | -18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Integrity Formulations Private Limited, buy the company report.
Board of directors of Integrity Formulations Private Limited
Integrity Formulations has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pareshkumar Narottambhai Patel | Additional Director | 15 Oct 2024 | 2 Years 0 Months | Current |
| Alkaben Sureshbhai Thakkar | Additional Director | 09 Nov 2022 | 3 Years 11 Months | Current |
| Upasna Dipesh Thakkar | Director | 19 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Integrity Formulations Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Three Dots Life Science Private Limited | ₹12.83 Cr (FY 2025) | 21.0% | Patna, Bihar, India | |||
| Regoshin Healthcare Private Limited | ₹12.81 Cr (FY 2024) | 25.0% | New Delhi, Delhi, India | |||
| Uniwend Medicals Pvt Ltd | ₹12.81 Cr (FY 2025) | -7.0% | Quilon, Kerala, India | |||
| Integrity Formulations Private Limitedthis company | ₹12.8 Cr (FY 2025) | -₹2.36 Cr | -18.4% | -34.0% | 24 | Vadodara, Gujarat, India |
| Allpharma Care Private Limited | ₹12.79 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Stein Pharma Private Limited | ₹12.77 Cr (FY 2017) | 1889.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Integrity Formulations Private Limited, buy the company report.
Auditor
Integrity Formulations Private Limited is audited by DARJI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DARJI & ASSOCIATES | FY 2022 | 116519W |
Shareholding
The shareholding of Integrity Formulations Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Integrity Formulations Private Limited, buy the company report.
Legal cases
Integrity Formulations Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by Ronam Healthcare Pvt. Ltd. Through Shiv Shanker | Pending |
| District court, Jabalpur, Madhya Pradesh | Court case (RCS B) | Filed against the company by M/S Bharat Distributors | Disposed |
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed against the company by M/S. Alive Bioscience Through Sanjay Jaiswal | Disposed |
To see the full case history of Integrity Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Integrity Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Integrity Formulations Private Limited has a workforce of 24 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
-11.11%
GST
Integrity Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCI0254F1Z0 | Gujarat | Active | 15 Mar 2021 |
To see the full GST registrations and return filing status of Integrity Formulations Private Limited, buy the company report.
Recent activity
Integrity Formulations Private Limited has 6 board changes on record since 2021: 3 appointments and 3 cessations. The latest: Alkaben Sureshbhai Thakkar ceased to be Additional Director on 17 Oct 2024.
AGM
Integrity Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Integrity Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Alkaben Sureshbhai Thakkar ceased to be Additional Director.
Appointed
Pareshkumar Narottambhai Patel was appointed as Additional Director.
Ceased
Pareshkumar Narottambhai Patel ceased to be Director.
Appointed
Alkaben Sureshbhai Thakkar was appointed as Additional Director.
Ceased
Sureshbhai Chimanlal Thakkar ceased to be Director.
Appointed
Upasna Dipesh Thakkar was appointed as Director.
Incorporation
19 Feb 2021
Integrity Formulations Private Limited was registered on 19 Feb 2021 with Roc Ahmedabad & aged 5 years 8 months as per MCA records.
Frequently asked questions
Integrity Formulations is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2021 (5+ years old) and is registered under CIN U24200GJ2021PTC120384.
Integrity Formulations has 3 current directors:
- Pareshkumar Narottambhai Patel - Additional Director
- Alkaben Sureshbhai Thakkar - Additional Director
- Upasna Dipesh Thakkar - Director
The latest financial statements of Integrity Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Integrity Formulations is 24AAGCI0254F1Z0, registered in Gujarat.
The CIN (Corporate Identification Number) of Integrity Formulations is U24200GJ2021PTC120384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Integrity Formulations has 3 court cases on record: 3 filed against it. 1 is pending.
Integrity Formulations was incorporated on 19 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Integrity Formulations by revenue are Three Dots Life Science Private Limited, Regoshin Healthcare Private Limited, Uniwend Medicals Pvt Ltd, Allpharma Care Private Limited, Stein Pharma Private Limited, all in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Alkaben Sureshbhai Thakkar ceased to be Additional Director on 17 Oct 2024. Pareshkumar Narottambhai Patel was appointed as Additional Director on 15 Oct 2024. Pareshkumar Narottambhai Patel ceased to be Director on 17 Nov 2022. Integrity Formulations has 6 board changes on record in total.
Yes, Integrity Formulations is registered as an MSME under Udyam registration (number: UDYAM-GJ-24-0018532).
The registered office of Integrity Formulations is at Shop No.37 Chhani Jakat Naka, Vadodara, Gujarat, India – 390024.